Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -21982.57% is 1247% below its 5-year average of -1631.77%, near the low end of its 5-year range (-23682.56%–97166.67%).
166.81% below its 12-month average of -8239.04%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5823.04%.
OPERATING MARGIN
-21982.57%
OPERATING MARGIN AVG TTM
-8239.04%
OPERATING MARGIN AVG 3Y
-1459.38%
OPERATING MARGIN AVG 5Y
-1631.77%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-166.81%
CURRENT VS 3Y AVG
-1406.29%
CURRENT VS 5Y AVG
-1247.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pulse Biosciences, Inc.
Market Cap
$3.43B
Operating Margin
-21982.57%
TTM Avg
-8239.04%
3Y Avg
-1459.38%
5Y Avg
-1631.77%
Market Cap
$3.39B
Operating Margin
7.59%
TTM Avg
16.94%
3Y Avg
-4.86%
5Y Avg
-19.92%
Market Cap
$3.48B
Operating Margin
-72.84%
TTM Avg
-2371.95%
3Y Avg
-1360.37%
5Y Avg
-967.05%
Market Cap
$3.49B
Operating Margin
-4974.27%
TTM Avg
-2487.14%
3Y Avg
-1585.80%
5Y Avg
-1144.82%
Market Cap
$3.51B
Operating Margin
-178.39%
TTM Avg
-262.24%
3Y Avg
-320.96%
5Y Avg
-353.79%
Market Cap
$3.33B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.33B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.43B | -21982.57% | -8239.04% | -1459.38% | -1631.77% |
| CareDx, Inc (CDNA)vs › | $3.39B | -0.92% | 2.81% | -22.73% | -18.78% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 7.59% | 16.94% | -4.86% | -19.92% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -72.84% | -2371.95% | -1360.37% | -967.05% |
| Celcuity Inc. (CELC)vs › | $3.49B | 0.00% | 0.00% | 0.00% | 0.00% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.49B | -4974.27% | -2487.14% | -1585.80% | -1144.82% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.51B | -178.39% | -262.24% | -320.96% | -353.79% |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.33B | 0.00% | 0.00% | 0.00% | 0.00% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.33B | 0.00% | 0.00% | 0.00% | 0.00% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | -1.17% | -12.22% | -19.38% | -20.83% |
Gross Margin
-360.0%
Operating Margin
-21982.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -5823.04% |
| 2026-03-31 | -4775.56% |
| 2025-12-31 | -6914.02% |
| 2025-09-30 | -23682.56% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 97166.67% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -5288.30% |
| 2022-03-31 | -3890.32% |
| 2021-12-31 | -1825.83% |
| 2021-09-30 | -2486.59% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
